Cargando…
The role of tramadol in current treatment strategies for musculoskeletal pain
Non-selective and cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drugs (NSAIDs) have been the mainstay of treatment for musculoskeletal pain of moderate intensity. However, in addition to gastrointestinal and renal toxicity, an increased cardiovascular risk may be a class effect...
Autor principal: | Schug, Stephan A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376082/ https://www.ncbi.nlm.nih.gov/pubmed/18472996 |
Ejemplares similares
-
Tramadol extended-release in the management of chronic pain
por: McCarberg, Bill
Publicado: (2007) -
Tramadol Extended-Release for the Management of Pain due to Osteoarthritis
por: Angeletti, Chiara, et al.
Publicado: (2013) -
Seizures associated with low-dose tramadol for chronic pain treatment
por: Beyaz, Serbülent Gökhan, et al.
Publicado: (2016) -
Tramadol: a valuable treatment for pain in Southeast Asian countries
por: Vijayan, Ramani, et al.
Publicado: (2018) -
The role of sensitization in musculoskeletal shoulder
pain
por: Borstad, John, et al.
Publicado: (2015)